How to Buy Xenon Pharmaceuticals Stock
Xenon Pharmaceuticals Inc
Xenon Pharmaceuticals Inc. , a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada.
Xenon Pharmaceuticals stock last closed at $35.32, up 0.4% from the previous day, and has decreased 19.12% in one year. It has overperformed other stocks in the Biotechnology industry by 0.28 percentage points. Xenon Pharmaceuticals stock is currently +6.16% from its 52-week low of $33.27, and -23.22% from its 52-week high of $46.00.
There are currently 76.54M XENE shares outstanding. The market capitalization of XENE is $2.70B. In the past 24 hours, 268,711 XENE shares were traded.
How to Buy Xenon Pharmaceuticals Stock
Wondering how to invest in Xenon Pharmaceuticals stock? Here's how.
- Choose where to buy Xenon Pharmaceuticals stock: You need to decide on a stock brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you choose where to buy Xenon Pharmaceuticals stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit money your brokerage account: Select your payment method and add your details.
- Analyze Xenon Pharmaceuticals stock: The Xenon Pharmaceuticals ticker symbol is XENE. Is Xenon Pharmaceuticals stock a good investment? Should you buy shares of XENE? How do XENE's underlying business fundamentals look? Do top analysts think Xenon Pharmaceuticals is a good buy? Why has XENE's stock price moved recently? (Hint: Our stock market analysis website can help you understand if XENE is a good stock to buy).
- Make your XENE trade: Decide if you will purchase XENE shares at the current market price or use a limit order to buy XENE shares at a particular price.
- Keep tabs on your XENE investment: Create a watchlist to monitor your new investment in Xenon Pharmaceuticals shares.
Step 1: Choose where to buy Xenon Pharmaceuticals stock
You will need a brokerage account to access the NASDAQ market and buy XENE shares.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best place to buy stocks. eToro gives you:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world financial markets: From Tech to Energy, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've picked the best brokerage, the next step is to fill out some personal information so you can invest in XENE stock today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to start a new trading account.
- Send your details by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you've filled out your info on the best stock market app, your next step is to transfer the money for your investment:
Watch this video walkthrough if you need help transferring funds into your new brokerage account.
Step 4: Analyze Xenon Pharmaceuticals stock
After you have decided on the best place to buy Xenon Pharmaceuticals stock, it's absolutely critical to analyze their stock prior to buying, so you truly comprehend the risk as well as the upside.
Xenon Pharmaceuticals stock quick numbers
Xenon Pharmaceuticals Due Diligence Checks
WallStreetZen was built to help part-time investors perform better fundamental analysis in less time.
You can view all of the due diligence checks on XENE's stock page.
Is XENE stock overvalued?
Investors use many financial metrics, analyses, models, and charts to gauge XENE's true value.
Using relative valuations methods:
- XENE could be undervalued based on its P/B ratio of 3.58x, relative to Biotechnology industry P/B ratio of 4.68x
You can access additional valuation analysis on XENE's stock here.
XENE Financial Health Summary
Signs that XENE is financially healthy:
- XENE has a low debt to equity ratio of 0.06.
- Total XENE debt is lower than 5 years ago, relative to shareholder equity.
- XENE has $626.91M in cash and short term investments. This is enough to cover its annual cash burn of $184.46M.
- There are more short-term assets than short-term liabilities on the XENE balance sheet.
- There are more short-term assets than long-term liabilities on the XENE balance sheet.
- XENE has cash burn of 184464000. It has enough cash and short-term investments to cover this for at least one year.
Is it a good time to buy XENE stock, according to analysts?
Out of 4 Wall Street analysts who give recommendations on XENE, the consensus analyst rating on Xenon Pharmaceuticals is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are projecting on the Xenon Pharmaceuticals stock forecast page.
XENE Momentum
How are XENE Revenues/Earnings doing?
Last year, XENE revenue was $0.00. Over the past 5 year, XENE's revenue has increased by -100% per year. This was slower than the Biotechnology industry average of 44.6%.
Learn more about XENE's earnings and revenue performance here.
Are XENE executives and large shareholders buying or selling the stock?
In the last 12 months, insiders at XENE have bought as many shares as they have sold.
Ian Mortimer, PRESIDENT CEO of XENE, was the latest XENE insider to buy. They bought $269,348.16 worth of XENE shares on Jan 27, 2025.
Get more info about who owns XENE shares here.
Can I rely on XENE as an income stream?
No, Xenon Pharmaceuticals doesn't provide an income stream by paying out dividends.
What others are saying about XENE
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Make your XENE trade
There are two primary options:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are usually sufficient. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at a specific price limit, use a limit order.
Press the Open Trade button and eToro will execute your order.
If you require additional help with buying stocks on eToro, watch the how to video below:
Step 6: Keep tabs on your XENE investment
Now that you own some XENE stock, you'll want to stay up-to-date on your new investment.
Add XENE to a watchlist to get notified of important updates regarding your XENE stock.
XENE Feed
How to Buy Stock in Xenon Pharmaceuticals
To summarize, here are the 6 steps for buying Xenon Pharmaceuticals stock:
- Choose where to buy Xenon Pharmaceuticals stock
- Open a brokerage account
- Deposit money your brokerage account
- Analyze Xenon Pharmaceuticals stock
- Make your XENE trade
- Keep tabs on your XENE investment
If you are looking for a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you would like to get notifications regarding your investment in Xenon Pharmaceuticals, get started below.
Related Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.